eubiologics

Products

Development and supply of safe and effective vaccine for global public health

Vaccine

Euvichol®

Euvichol® is an oral cholera vaccine developed to prevent cholera outbreaks in low and middle-income countries. Since it does not require a syringe, it has the advantage of avoiding localized adverse effects such as pain, swelling, or rashes at the injection site. With these benefits, Euvichol® is supplied at an affordable price to low-income countries affected by cholera through international organizations such as UNICEF. Developed by a domestic biotech venture, Euvichol became the first vaccine of its kind to receive WHO Prequalification in December 2015.
Product Name Euvichol®(Inactivated oral cholera vaccine)
Product Purpose Prescription drugs (for export)
Dosage and Administration Administer orally twice at two-week intervals
Appearance A colorless, clear glass vial containing a yellow or slightly yellowish cloudy solution containing inactivated cholera bacteria.
Efficacy / Effectiveness Prevention of cholera caused by Vibrio cholerae serogroup O1 in children, adolescents, and adults over 1 year of age. (However, efficacy against Vibrio cholerae serogroup O139 has not been confirmed.)
manual brochure
Euvichol-Plus

Product Components

Active ingredient Quantity
V. cholerae O1 Inaba Cairo 48 (H) 300 L.E.U*
V. cholerae O1 Inaba Phil 6973 El Tor (F) 600 L.E.U
V. cholerae O1 Ogawa Cairo 50 (F) 300 L.E.U
V. cholerae O1 Ogawa Cairo 50(H) 300 L.E.U
V. cholerae O139 4260B (F) 600 L.E.U

H:Heat inactivated F:Formalin inactivated

* LEU : Lipopolysaccharide ELISA Units

Product Information

Dosage and schedule Storage Shelf-life
/Administer orally twice at two-week intervals Store at a temperature between 2℃ and 8℃ 24 months from manufacturing date